Sionna Therapeutics, Inc. Common Stock (SION) earnings · next report Nov 4, 2026
Next report
Wed, Nov 4, 2026
Time not announced · Today
Quarter ended Sep 2026
- EPS consensus
- −$0.62 Range −$0.84 – −$0.538 analystsYear ago −$0.46
- Revenue consensus
- $0 Range $0 – $010 analysts
EPS estimate trend
- 90 days ago−$0.65
- 60 days ago−$0.65
- 30 days ago−$0.67
- 7 days ago−$0.67
- Now−$0.68
Consensus −4.1% over 90 days. Last 30 days: 2 up, 1 down revisions.
Date and consensus: EODHD earnings calendar and estimates, refreshed every 6 hours. “Confirmed” means the provider lists the report session, which it sets once the company announces; “Estimated” is the provider’s expected date.
Follow SION into its report
Save it to a free watchlist (no card). Alerts when the date moves or results land are part of Pro.
Earnings move
- Options price in (Nov 4)
- ±69.2% Priced at the Nov 3 close · expiry Nov 20 (17 days: includes non-earnings days)
- Average move after earnings
- ±7.8% Absolute close-to-close move, 2 reports
Options expect a bigger move than SION’s average after earnings (±69.2% vs ±7.8%).
Options-implied move: the at-the-money straddle (call + put) on the first expiry after the report, divided by the stock’s close, from EODHD end-of-day option chains. It is what the options market prices as the absolute move to that expiry, not a forecast of direction. Move: close before the news → close after it (before the open: prior close → report-day close; after the close: report-day close → next close), adjusted for splits and dividends, from EODHD end-of-day prices. Reports with an unannounced time are not averaged: both candidate moves are stored instead. Per-report moves, gaps, moves vs SPY and the sector, beat/miss asymmetry and implied vs actual are in Lician Pro below.
Latest result
EPSGAAP
−$0.66
vs −$0.64 est. −3.1%
GAAP diluted EPS, SEC 10-Q
Revenue
—
No revenue consensus stored
EPS actuals are checked against the SEC filing and the company’s earnings press release (8-K EX-99.1). A company that reports only GAAP EPS is graded on its SEC diluted EPS; one that reports adjusted EPS is graded on the provider’s adjusted figure when the release confirms it. A figure that matches neither is shown as unverified, with no beat or miss. Revenue actuals come from the SEC filing of the same quarter where we have it.
Beat / miss history
- Missed EPS 2 quarters in a row
- Beat EPS in 2 of 4
- Aug 6, 2026MissEPS −$0.66GAAP vs −$0.64 −3.1%Rev — vs —
- May 12, 2026MissEPS −$0.60GAAP vs −$0.50 −20.0%Rev — vs —
- Mar 19, 2026BeatEPS −$0.46GAAP vs −$0.71 +35.2%Rev — vs —
- Nov 5, 2025BeatEPS −$0.46GAAP vs −$0.52 +11.5%Rev — vs —
| Reported | Quarter | EPS est. | EPS actual | Surprise | Revenue est. | Revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | Jun 2026 | −$0.64 | −$0.66GAAP | −3.1% | — | — | — |
| May 12, 2026 | Mar 2026 | −$0.50 | −$0.60GAAP | −20.0% | — | — | — |
| Mar 19, 2026 | Dec 2025 | −$0.71 | −$0.46GAAP | +35.2% | — | — | — |
| Nov 5, 2025 | Sep 2025 | −$0.52 | −$0.46GAAP | +11.5% | — | — | — |
Earnings documents
- Earnings press releaseEX-99.1 · 8-K filed Aug 6, 2026Open on SEC.gov
Read the filing on LicianEDGAR filing index
Documents link to SEC EDGAR. Lician does not publish earnings-call transcripts.
Healthcare peers with similar quant ratings
SION is rated 2.03 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- HROW earnings2.06 · Sell · stock
- KURA earnings2.06 · Sell · stock
- EBS earnings2.04 · Sell · stock
- PSNL earnings2.03 · Sell · stock
- EWTX earnings2.02 · Sell · stock
- MASS earnings2.00 · Sell · stock
- WHWK earnings2.00 · Sell · stock
- AVBP earnings1.99 · Sell · stock
| Quarter | Revenue | EPS | YoY |
|---|---|---|---|
| Q2 FY26 | — | −$0.66 | — |
| Q1 FY26 | — | −$0.60 | — |
| Q3 FY25 | — | −$0.46 | — |
| Q2 FY25 | — | −$410.00 | — |
Sionna Therapeutics, Inc. Common Stock (SION) is a biotechnology company listed on US.
No cached income statement for SION yet, so there is no earnings base to recap.
When the next SION 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for SION. We will not invent a beat or miss.
Not investment advice. Full SION research stays on the stock page; the tape stays on the quote page.
SION earnings FAQ
When is SION's next earnings date?
Sionna Therapeutics, Inc. Common Stock (SION) is expected to report on Wed, Nov 4, 2026. This is the provider’s estimated date; the company has not confirmed it. Consensus EPS is −$0.62.
Did SION beat earnings estimates last quarter?
No. On Aug 6, 2026 Sionna Therapeutics, Inc. Common Stock (SION) reported adjusted EPS of −$0.66 against a −$0.64 consensus (−3.1%), a miss.
How often does SION beat EPS estimates?
Sionna Therapeutics, Inc. Common Stock (SION) beat the EPS consensus in 3 of its last 6 reported quarters.
Not investment advice.